Less Ads, More Data, More Tools Register for FREE

CAP-XX-THALES Feasibility Study

8 Apr 2015 07:00

RNS Number : 5479J
CAP-XX Limited
08 April 2015
 



CAP - XX Limited

("CAP - XX" or the "Company")

 

CAP-XX-THALES Feasibility Study

 

CAP-XX has signed an R&D agreement with the Thales Research Centre. As part of the agreement Thales contracts CAP-XX to evaluate innovative technology developed by Thales and to examine CAP-XX's own technology according to the stringent requirements of the avionics market. This initial study is a first step towards the use of supercapacitors that target avionics applications. The Thales Research Centre located in Palaiseau (Paris, France), is one of five major Thales research centres and a pioneer of the company's open innovation approach.

 

 

CAP-XX LimitedAnthony Kongats (Chief Executive Officer)

 

+61 (0) 2 9428 0139

Cenkos Securities (Nominated Adviser and Joint Broker)Stephen Keys/Mark Connelly

 

+44 (0) 20 7397 1949

 

Allenby Capital Limited (Joint Broker)David Hart/Alex Brearley

 

+44 (0) 20 3328 5656

 

Kreab Robert Speed (Financial PR) 

 

 

+44 (0) 20 7074 1800

 

Notes to editors

 

About CAP-XX

CAP-XX (LSE:CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADDLFBEZFBBBF

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS